
PhaseBio Pharmaceuticals to Host Virtual Investor and Analyst Day
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, announced that it will host a …
Read More